PD-0455: Investigating a correlation between chemoradiotherapy schedule and survival in limited disease SCLCManapov, F.; Niyazi, M.; Oskan, F.; Hildebrandt, G.; Klautke, G.; Fietkau, R.; Belka, C. · Radiotherapy and Oncology · 2013

OC-0501 Chemo-RT plus induction or consolidation chemotherapy for rectal cancer: a randomised phase 2 trialFokas, E.; Allgäuer, M.; Polat, B.; Klautke, G.; Grabenbauer, G.; Fietkau, R.; Kuhnt, T.; Staib, L.; Brunner, T.; Grosu, A.L.; Schmiegel, W.; Jacobasch, L.; Weitz, J.; Folprecht, G.; Schleska-Lange, A.; Grützmann, R.; Schwarzbach, M.; Paolucci, V.; Bechstein, W.O.; Friede, T.; Ghadimi, M.; Hofheinz, R.D.; Rödel, C. · Radiotherapy and Oncology · 2019

Phase I/II clinical trial of concurrent radiochemotherapy in combination with topotecan for the treatment of brain metastasesK Grüschow; G Klautke; R Fietkau · 2002

Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancerKlautke, G; Feyerherd, P; Ludwig, K; Prall, F; Foitzik, T; Fietkau, R · British Journal of Cancer · 2005

Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II studyKlautke, G; Küchenmeister, U; Foitzik, T; Ludwig, K; Prall, F; Klar, E; Fietkau, R · 2006

O-011Randomized phase 2 trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12Hofheinz, R; Fokas, E; Allgäuer, M; Polat, B; Klautke, G; Grabenbauer, G; Fietkau, R; Kuhnt, T; Staib, L; Brunner, T; Grosu, A; Schmiegel, W; Jacobasch, L; Weitz, J; Folprecht, G; Germer, C; Grützmann, R; Schwarzbach, M; Bechstein, W; Friede, T; Ghadimi, M; Rödel, C · Annals of Oncology · 2019

1124PSingle cycle induction treatment with cisplatin/docetaxel plus durvalumab/tremelimumab in stage III-IVB head and neck squamous cell cancer (CheckRad-CD8 trial)Hecht, M; Gostian, A-O; Eckstein, M; Rutzner, S; von der Grün, J; Illmer, T; Hautmann, M G; Brunner, T; Laban, S; Klautke, G; Tamaskovics, B; Frey, B; Hartmann, A; Rödel, C; Budach, W; Gaipl, U; Iro, H; Fietkau, R · Annals of Oncology · 2019

Evolving treatment strategies for myelomaMorgan, G J; Davies, F E · British Journal of Cancer · 2005

Exploiting nanotechnology to target cancerSengupta, S; Sasisekharan, R · British Journal of Cancer · 2007

Selection of controlsvon Euler-Chelpin, M; Lynge, E · British Journal of Cancer · 2007

The Treatment of Retinal GliomaJapha, E M · British Journal of Cancer · 1949

Author IndexBritish Journal of Cancer · 1947

Screening Tests in Chemical CarcinogenesisFox, M · British Journal of Cancer · 1976

Fundamentals of Cancer ChemotherapyBush, H · British Journal of Cancer · 1979

Tumour Markers: impact and ProspectsCoombes, R C · British Journal of Cancer · 1980